Expanded Access to Retatrutide Offered for Severe Obesity Cases | Retatrutide News

Eli Lilly is offering expanded access to retatrutide for adults with severe obesity who cannot join clinical trials. This access targets those with a BM...
Clinical Trials · October 17, 2026